US 10301393
Methods of treating multiple sclerosis using anti-CD20 antibodies
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 10301393 (Methods of treating multiple sclerosis using anti-CD20 antibodies) held by VACCINEX, INC. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61K39/39558, A61P